More evidence points to the benefits of germline genetic testing for patients with various cancers. Such testing can identify mutations that may warrant a change of treatment and allow trying a ...

Dr. Evan Yu presents the new evidence-based guideline on genetic testing for metastatic prostate cancer. He discusses who should receive germline and somatic testing with next-generation sequencing ...

Comprehensive somatic CGP at diagnosis enables identification of actionable alterations, therapeutic targets, resistance mutations, and clinical trial eligibility, tightening alignment between tumor ...

Please provide your email address to receive an email when new articles are posted on . Most patients with cancer who have genetic variants linked to their disease view it as their responsibility to ...

From 7% to nearly 9% of patients with advanced cancer were found to harbor a germline variant with targeted therapeutic actionability in the first study of its kind. The study involved 11,974 patients ...

BOSTON & EL MONTE, Calif.--(BUSINESS WIRE)-- Foundation Medicine, Inc., a genomics company committed to transforming cancer care, today announced plans to launch two new germline tests, ...

Please provide your email address to receive an email when new articles are posted on . Nearly all individuals who self-navigated the entire online platform completed germline testing. The platform ...

Genetic testing for ovarian cancer may help inform treatment decisions for patients with advanced disease, particularly regarding PARP inhibitor use. Although multiple factors might affect the utility ...

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. Whole Genome Sequencing (WGS) test now available ...

Addressing Tumor Board Bad Habits and Risks: A Call for Rational Resource Management Fig 1. Summary of germline and somatic genomic testing for metastatic prostate cancer recommendations. ARPI, ...